Proteomic Investigations of Alcoholic Hepatitis
Proteomic Investigations of Alcoholic Hepatitis
批准号:
9124607
负责人:
Jon Jacobs
金额:
$26.67万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-20 至 2018-08-31
关键词:
Adrenal Cortex HormonesAlcoholic HepatitisAlcoholic Liver CirrhosisAlcoholic Liver DiseasesAscitesBiological AssayBlood CellsCaliforniaCellsCessation of lifeClinicalClinical TrialsData AnalysesDetectionDevelopmentDiseaseDisease ProgressionEnzyme-Linked Immunosorbent AssayGoalsHealthHealthcare SystemsHeavy DrinkingHepatocyteHistocytochemistryHistologyImmunologyInterleukin-1InvestigationLaboratoriesLinkLiverMapsMeasurementMeasuresMolecularMolecular ProfilingMycophenolatePacific NorthwestPathologyPathway interactionsPatientsPlasmaPopulationPopulation ControlProteinsProteomeProteomicsPublic HealthResearch PersonnelSystemTechnologyTissuesTranslational ResearchTreatment outcomeUnited StatesWorkbasecell injurycytokinedata integrationinterestliquid chromatography mass spectrometrymolecular markermortalityprednisoloneprotein biomarkersprotein profilingresponsetranscriptometreatment effecttreatment response
中文摘要
描述(申请人提供):过量饮酒是一个主要的全球公共卫生问题,酒精性肝病(ALD)是美国肝脏相关死亡的主要原因。酒精性肝炎(AH)终生发病率高达20%,是一种
特别严重的ALD,短期死亡率高。本工作的重点是将灵敏的液质联用(LC-MS)平台广泛应用于蛋白质丰度的检测和定量,用于AH的分子机制研究。在蛋白质组学技术应用于肝脏相关疾病的研究方面,以前已经进行了大量的工作,但尚未应用于临床
调查阿赫。这类技术能够提供对关键生物体液、细胞和组织的公正看法,在这些方面,人们对急性肝炎的发病机制、疾病进展的分子特征以及重要的有助于确定治疗结果和评估新治疗方案的任何特征了解有限。我们将结合使用血浆、肝组织和分离的循环血细胞的临床试验,将基于发现和验证的蛋白质组学技术应用于AH的研究,以确定接受皮质类固醇和抗细胞因子治疗的患者表达和/或分泌的分化蛋白质集。这项研究的目标将是识别和验证关键的分子标记和整合的途径,这将澄清对AH疾病进展机制和潜在治疗效果的理解。蛋白质水平的结果与U01联盟进行的补充研究的相关性、整合和功能图谱将为系统水平的初步发现和解释提供重要的背景。
英文摘要
DESCRIPTION (provided by applicant): Excessive alcohol consumption is a major global public health issue, with alcoholic liver disease (ALD) being a leading cause of liver-related death in the United States. Alcoholic hepatitis (AH), at up to a 20% lifetime occurrence rate, is a
particularly serious form of ALD with high short term mortality rates. This work focuses on the application of sensitive liquid chromatography-mass spectrometry (LC-MS) platforms for the broad detection and quantification of protein abundances towards the molecular mechanistic study of AH. Significant previous work has been performed in the application of proteomic technologies towards the study of liver related diseases, but it has not been applied clinically to
investigate AH. Such technologies have the ability to provide an unbiased view of key biofluids, cells, and tissues, where there is limited understanding concerning the mechanistic onset of AH, the molecular signatures of disease progression, and importantly any signatures which can help determine treatment outcomes and assess new treatment regiments. We will apply both discovery and verification-based proteomic technologies towards the investigation of AH in conjunction with a clinical trial using blood plasma, liver tissue, and isolated circulating blood cells, to determine the differentiating set of expressed and/or secreted proteins for patients undergoing corticosteroid and anti-cytokine treatment. The goals of this study will be to identify and verify key molecular markers and integrated pathways which would clarify understanding of the mechanism of AH disease progression and potential treatment effects. Correlation, integration, and functional mapping of the protein-level results with complementary studies performed across the U01 consortium will provide important context to initial findings and interpretations at the systems level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel high resolution MS platform for high-throughput screening of G protein-coupled receptors
-
批准号:10636377
-
项目类别:
-
资助金额:$34.23万
-
财政年份:2023
-
负责人:Jon Jacobs
-
依托单位:
Spatial analysis of Alcoholic Hepatitis Liver Tissue
-
批准号:10261590
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2020
-
负责人:Jon Jacobs
-
依托单位:
PSP Omics Center of Acute to Chronic Pain Signatures
-
批准号:10863382
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
PSP Omics Center of Acute to Chronic Pain Signatures
-
批准号:10231045
-
项目类别:
-
资助金额:$137.52万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
PSP-Administrative Core
-
批准号:10863383
-
项目类别:
-
资助金额:$9.98万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
PSP Omics Center of Acute to Chronic Pain Signatures
-
批准号:10459355
-
项目类别:
-
资助金额:$67.86万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
PSP Omics Center of Acute to Chronic Pain Signatures
-
批准号:9812788
-
项目类别:
-
资助金额:$6.65万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
PSP-Administrative Core
-
批准号:10231046
-
项目类别:
-
资助金额:$137.52万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
PSP Omics Center of Acute to Chronic Pain Signatures
-
批准号:10611136
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
PSP-Administrative Core
-
批准号:10459356
-
项目类别:
-
资助金额:$67.86万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
PSP-Administrative Core
-
批准号:9812789
-
项目类别:
-
资助金额:$6.65万
-
财政年份:2019
-
负责人:Jon Jacobs
-
依托单位:
Proteomic Investigations of Alcoholic Hepatitis
-
批准号:8903768
-
项目类别:
-
资助金额:$26.05万
-
财政年份:2013
-
负责人:Jon Jacobs
-
依托单位:
Proteomic Investigations of Alcoholic Hepatitis
-
批准号:9332306
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2013
-
负责人:Jon Jacobs
-
依托单位:
A Research Resource for Ultra-sensitive and High Throughput Proteomics - Driving Biomedical Projects
-
批准号:10461821
-
项目类别:
-
资助金额:$20.56万
-
财政年份:2003
-
负责人:Jon Jacobs
-
依托单位:
A Research Resource for Ultra-sensitive and High Throughput Proteomics - Driving Biomedical Projects
-
批准号:10220052
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2003
-
负责人:Jon Jacobs
-
依托单位:
海外基金